DUBLIN, March 24, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the first patient implants in the TITAN 2 pivotal study that will evaluate ...
Medtronic has received FDA approval for a new implant aimed at improving bladder control, with a small device placed near the ...
The FDA has approved an app-based smart programming device used to discreetly and easily control implants treating for overactive bladder (OAB), chronic fecal incontinence (FI) and non-obstructive ...
Many people have problems controlling urination and no medications or therapies seem to help. A special implant could be the answer Lila Forrest and other patients have been looking for. For many ...
TITAN 2 pivotal study to evaluate implantable tibial neuromodulation (TNM) device to help expand patient access to advanced therapy DUBLIN, March 24, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback